Dental and Medical Problems

Dent Med Probl
Index Copernicus (ICV 2020) – 128.41
MEiN – 70 pts
CiteScore (2021) – 2.0
JCI – 0.5
Average rejection rate (2021) – 81.35%
ISSN 1644-387X (print)
ISSN 2300-9020 (online)
Periodicity – quarterly

Download original text (EN)

Dental and Medical Problems

2020, vol. 57, nr 2, April-June, p. 145–148

doi: 10.17219/dmp/114440

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

Comparison of salivary total antioxidant levels in male smokers and non-smokers according to their personality types

Porównanie całkowitej zdolności antyoksydacyjnej śliny u palących i niepalących mężczyzn w odniesieniu do ich typów osobowości

Hamed Mortazavi1,A,E,F, Azadeh Ghasemi2,B,C, Mohammad Reza Vatankhah3,C,D

1 Department of Oral Medicine, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Dental private office, Tehran, Iran

3 Students’ Research Committee, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Background. Cigarette smoking is a major global health problem, associated with various oral diseases, such as oral cancers. Salivary antioxidants may play an important role in fighting against radicals and the oxidative components of cigarettes, which can cause DNA damage. Furthermore, psychological stress, which occurs more often in individuals with type A personality, affects plasma antioxidant levels.
Objectives. The objective of this study was to compare the levels of salivary total antioxidant capacity (TAC) between smokers and non-smokers according to their personality types.
Material and Methods. In this descriptive cross-sectional study, saliva samples were collected from 40 male smokers (with ≥0.1 pack-years) and 40 male non-smokers. After centrifugation, the samples were assessed using an enzyme-linked immunosorbent assay (ELISA) kit. Pearson’s correlation, Welch’s t-test and the one-way analysis of variance (ANOVA) test were used for statistical analyses.
Results. The TAC of saliva in smokers was significantly lower than in non-smokers (p = 0.019). Type A and type B smokers showed no significant decrease in TAC (p > 0.05 and p = 0.05, respectively) as compared to type A and type B non-smokers, respectively. Type A smokers reported a higher number of cigarettes smoked per day as compared to smokers with type B personality (p = 0.043).
Conclusion. Smoking cigarettes was associated with a significant decrease in salivary TAC. However, the personality type did not affect salivary TAC in the present study.

Key words

personality, antioxidants, saliva, antioxidant, smoking tobacco

Słowa kluczowe

osobowość, antyoksydanty, ślina, antyoksydacyjny, palenie tytoniu

References (29)

  1. Warnakulasuriya S. Causes of oral cancer – an appraisal of controversies. Br Dent J. 2009;207(10):471–475.
  2. Abdolsamadi HR, Goodarzi MT, Mortazavi H, Robati M, Ahmadi-Motemaye F. Comparison of salivary antioxidants in healthy smoking and non-smoking men. Chang Gung Med J. 2011;34(6):607–611.
  3. Proia NK, Paszkiewicz GM, Sullivan Nasca MA, Franke GE, Pauly JL. Smoking and smokeless tobacco-associated human buccal cell mutations and their association with oral cancer – a review. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1061–1077.
  4. Johnson GK, Guthmiller JM. The impact of cigarette smoking on periodontal disease and treatment. Periodontol 2000. 2007;44:178–194.
  5. Jahanbani J. Prevalence of oral leukoplakia and lichen planus in 1,167 Iranian textile workers. Oral Dis. 2003;9(6):302–304.
  6. Pryor WA, Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci. 1993;686:12–27.
  7. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene. 2002;21(48):7435–7451.
  8. Choudhari SK, Chaudhary M, Gadbail AR, Sharma A, Tekade S. Oxidative and antioxidative mechanisms in oral cancer and precancer: A review. Oral Oncol. 2014;50(1):10–18.
  9. Battino M, Ferreiro MS, Gallardo I, Newman HN, Bullon P. The antioxidant capacity of saliva. J Clin Periodontol. 2002;29(3):189–194.
  10. Bakhtiari S, Azimi S, Mehdipour M, Amini S, Elmi Z, Namazi Z. Effect of cigarette smoke on salivary total antioxidant capacity. J Dent Res Dent Clin Dent Prospects. 2015;9(4):281–284.
  11. Bakhtiari S, Taheri JB, Bakhshi M, et al. Effect of vitamin C on sali­vary total antioxidant capacity in smokers. Iran J Pharm Res. 2012;11(4):1045–1049.
  12. Zappacosta B, Persichilli S, De Sole P, Mordente A, Giardina B. Effect of smoking one cigarette on antioxidant metabolites in the saliva of healthy smokers. Arch Oral Biol. 1999;44(6):485–488.
  13. Kusano C, Ferrari CKB. Total antioxidant capacity: A biomarker in biomedical and nutritional studies. J Cell Mol Biol. 2008;7(1):1–15.
  14. Yanik M, Erel O, Kati M. The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatr. 2004;16(4):200–203.
  15. Moriana JA, Herruzo J. Type A behavior pattern as a predictor of psychiatric sick-leaves of Spanish teachers. Psychol Rep. 2005;96(1):77–82.
  16. Lee YH, Shin MH, Kweon SS, et al. Cumulative smoking exposure, duration of smoking cessation, and peripheral arterial disease in middle-aged and older Korean men. BMC Public Health. 2011;11:94.
  17. Navazesh M, Kumar SKS. Measuring salivary flow: Challenges and opportunities. J Am Dent Assoc. 2008;139(Suppl):35S–40S.
  18. Walsh JJ, Wilding JM, Eysenck MW. Stress responsivity: The role of individual differences. Pers Individ Differ. 1994;16(3):385–394.
  19. Farnodi F, Amiri H, Jalali R. The association of personality type A and B to type 2 diabetes mellitus in patients referring to diabetes center, Kermanshah, 2014. J Clin Res Paramed Sci. 2015;4(3):188–194.
  20. Roushan CR, Modaresi F. Personality types and mental health impact of systemic lupus erythematosus and rheumatoid arthritis. Hakim Res J. 2003;5(4):255–261.
  21. Jha P, Ranson MK, Nguyen SN, Yach D. Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health. 2002;92(6):1002–1006.
  22. Ebadi M, Vahdaninia M, Azin A, et al. Prevalence of tobacco consumption: Iranian health perception survey. Payesh. 2011;10(3):365–372.
  23. Lettrichová I, Tóthová L, Hodosy J, Behuliak M, Celec P. Variability of salivary markers of oxidative stress and antioxidant status in young healthy individuals. Redox Rep. 2016;21(1):24–30.
  24. Charalabopoulos K, Assimakopoulos D, Karkabounas S, Danielidis V, Kiortsis D, Evangelou A. Effects of cigarette smoking on the antioxidant defence in young healthy male volunteers. Int J Clin Pract. 2005;59(1):25–30.
  25. Nagler RM. Altered salivary profile in heavy smokers and its possible connection to oral cancer. Int J Biol Marker. 2007;22(4):274–280.
  26. Oyefeso AO, Odeyale MA. Smoking and type A behaviour. Scand J Psychol. 1991;32(1):79–81.
  27. Hughes JR, Pickens RW, Gust SW, Hatsukami DK, Svikis DS. Smoking behavior of type A and type B smokers. Addict Behav. 1986;11(2):115–118.
  28. Chattopadhyay K, Chattopadhyay BD. Effect of nicotine on lipid profile, peroxidation & antioxidant enzymes in female rats with restricted dietary protein. Indian J Med Res. 2008;127(6):571–576.
  29. de Cássia Rondina R, Gorayeb R, Botelho C. Psychological characteristics associated with tobacco smoking behavior. J Bras Pneumol. 2007;33(5):592–601.
© Wroclaw Medical University